Acerus Pharmaceuticals (FRA:3TP0) Days Sales Outstanding : 108.43 (As of Sep. 2022)

View and export this data going back to 2014. Start your Free Trial

What is Acerus Pharmaceuticals Days Sales Outstanding?

Acerus Pharmaceuticals's average Accounts Receivable for the three months ended in Sep. 2022 was €0.92 Mil. Acerus Pharmaceuticals's Revenue for the three months ended in Sep. 2022 was €0.78 Mil. Hence, Acerus Pharmaceuticals's Days Sales Outstanding for the three months ended in Sep. 2022 was 108.43.

The historical rank and industry rank for Acerus Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

FRA:3TP0's Days Sales Outstanding is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 71.44
* Ranked among companies with meaningful Days Sales Outstanding only.

Acerus Pharmaceuticals's Days Sales Outstanding declined from Sep. 2021 (227.12) to Sep. 2022 (108.43).

Acerus Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Acerus Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acerus Pharmaceuticals Days Sales Outstanding Chart

Acerus Pharmaceuticals Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Days Sales Outstanding

Get a 7-Day Free Trial

69.80

55.81

51.02

89.20

Acerus Pharmaceuticals Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Days Sales Outstanding	Get a 7-Day Free Trial															227.12	123.67	48.45	85.32	108.43

Competitive Comparison of Acerus Pharmaceuticals's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Acerus Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acerus Pharmaceuticals's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Acerus Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Acerus Pharmaceuticals's Days Sales Outstanding falls into.

Acerus Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Acerus Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Dec. 2021 is calculated as

	Days Sales Outstanding (A: Dec. 2021 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2020 )	+	Accounts Receivable (A: Dec. 2021 ))	/	count )	/	Revenue (A: Dec. 2021 )	*	Days in Period
=	( (0.363	+	0.275)	/	2 )	/	-3.658	*	365
=	0.319					/	-3.658	*	365
=	N/A

Acerus Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Sep. 2022 is calculated as:

	Days Sales Outstanding (Q: Sep. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2022 )	+	Accounts Receivable (A: Sep. 2022 ))	/	count )	/	Revenue (A: Sep. 2022 )	*	Days in Period
=	( (0.845	+	1.004)	/	2 )	/	0.778	*	365 / 4
=	0.9245					/	0.778	*	365 / 4
=	108.43

Acerus Pharmaceuticals (FRA:3TP0) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Acerus Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Acerus Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Acerus Pharmaceuticals (FRA:3TP0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Acerus Pharmaceuticals Corp (FRA:3TP0) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

7025 Langer Drive, Suite 205, Mississauga, ON, CAN, L5N 0E8

Website

https://www.aceruspharma.com

Acerus Pharmaceuticals Corp is a specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of branded products that improve patient experience, with a primary focus on the field of men's health. Its foundational product includes NATESTO, a testosterone therapy based on nasal gel technology. The company commercializes its products via its salesforce in the United States and Canada, and through a global network of licensed distributors in other territories.

Acerus Pharmaceuticals (FRA:3TP0) Headlines

No Headlines